This federal contract award, valued at $13,547.42, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of TABRECTA 200 MG TABLET UU 56S, a specialty medication, with a completion date of December 30, 2024.
Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries through a streamlined, comprehensive contracting mechanism.
The contract award reviewed does not have a set-aside designation, indicating open competition. Amerisourcebergen, as the prime contractor, is responsible for delivering the requested products, with no major subcontractors mentioned in the information provided.
Generated 3/7/25, 9:42 AM